Fulgent Genetics (FLGT) Shares Outstanding (2015 - 2026)

Fulgent Genetics has disclosed Shares Outstanding (Entity) across 12 years of filings, most recently posting $27.5 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 10.11% year-over-year to $27.5 million; the TTM figure through Jun 2026 stood at $27.5 million (down 10.11% YoY), while the FY2025 annual figure was $31.1 million, up 0.78% from the prior year.
• Shares Outstanding (Entity) came in at $27.5 million for Q2 2026 at Fulgent Genetics, down from $28.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $31.1 million in Q4 2025 to a low of $27.5 million in Q2 2026.
• Average Shares Outstanding (Entity) over 5 years is $30.0 million, with a median of $30.1 million recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) increased 4.62% in 2022 and retreated 10.11% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $29.4 million in 2022, then rose by 0.73% to $29.7 million in 2023, then gained by 4.01% to $30.8 million in 2024, then advanced by 0.78% to $31.1 million in 2025, then declined by 11.47% to $27.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $27.5 million in Q2 2026, $28.9 million in Q1 2026, and $31.1 million in Q4 2025.